Found: 10
Select item for more details and to access through your institution.
Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 147, n. 3, p. 599, doi. 10.1007/s11060-020-03479-8
- By:
- Publication type:
- Article
Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 132, n. 2, p. 351, doi. 10.1007/s11060-017-2377-0
- By:
- Publication type:
- Article
Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 113, n. 3, p. 365, doi. 10.1007/s11060-013-1135-1
- By:
- Publication type:
- Article
Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05077-2
- By:
- Publication type:
- Article
Somatostatin Receptor Ligand Therapy—A Potential Therapy for Neurocytoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 6, p. 2395, doi. 10.1210/jc.2018-02419
- By:
- Publication type:
- Article
Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 6, p. 1020, doi. 10.1093/neuonc/noab276
- By:
- Publication type:
- Article
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1184, doi. 10.1093/neuonc/noz078
- By:
- Publication type:
- Article
Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141334
- By:
- Publication type:
- Article